Also found in: Medical.
CDK5Cyclin-Dependent Kinase 5
References in periodicals archive ?
MKP1, ERK1, CDK2 and CDK5, CDC25, and MMP9 appear as appealing candidate (Table 1).
The double-stain fluorescent method also demonstrated that HIgs held antagonistic effects on Ab-caused toxicity among nerve cells Through the exploration of the mechanism of HIgs' antagonistic effects on Ab-caused toxicity among nerve cells, it was found that HIg inhibited the cleavage of P35 to P25, prevented the over- activation of CDK5, and lowered the over- phosphorylation of tau proteins in the cytoskeletons of cerebral cells, thus avoiding the damages in cerebral nerve cells.
A further set of experiments confirmed the results of present study and a decrease in CDK5 and ERK 1/2 activity was recorded in the sciatic nerve compartment of mice following inoculation in the hind foot pad with M.
However, two key studies published in Nature and authored by Ember founders show that it is the inhibition of CDK5 phosphorylation of this nuclear hormone receptor that is the therapeutic driver of the anti-diabetic effect, while the receptor agonism is the driver of the adverse events associated with these therapies.
sup][8] The down-regulation of CDKAL1 expression might increase the activity of CDK5, resulting in decreased insulin secretion, [sup][9] while the exact mechanisms are not clear.
Objective: This proposal is intended to develop biosensors, named CDKACT and CDKCONF, as smart tools to detect and study key cancer biomarkers, such as CDK4 and CDK5 kinases, which may be of potential value for cancer diagnostic and theragnostic purposes, as well as to propose new selective compounds for cancer therapeutics by screening for non-ATP-competitive inhibitors of these targets.
Numerous studies confirmed that a variety of protein kinase, such as GSK-3, CDK5, MAPK and phosphate enzymes involved in the phosphorylation of tau protein (Gordon-Krajcer et al.
CDK5 and MEKK1 mediate pro-apoptotic signaling following endoplasmic reticulum stress in an autosomal dominant retinitis pigmentosa model.